Autoimmune diabetes is characterized by the selective destruction of ?-cells that occurs during an inflammatory reaction in and around pancreatic islets. Inflammatory cytokines, released during this process, impair ?-cell function and can induce ?-cell death. Cytokines have also been implicated in the loss of functional ?-cell mass during the development of type 2 diabetes. The broad goals of this research are to elucidate the cellular mechanisms that are responsible the functional impairment and death of pancreatic ?-cell following cytokine treatment, and to identify pathways by which ?-cells protect themselves against cytokine-mediated damage. Reactive nitrogen species (RNS;e.g., nitric oxide) are primary mediators of the damaging actions of interleukin-1 (IL-1) and interferon (IFN)-??on ?-cell function and viability. We have shown that nitric oxide can also activate "protective pathways" that lead to the recovery of insulin secretory function, mitochondrial oxidative metabolism, and the repair of damaged DNA. It is the delicate balance between the toxic and protective actions of RNS, produced by ?-cells in response to cytokines that ultimately determines whether these cells survive or die. This proposal will elucidate the pathways that control ?-cell fate following cytokine treatment. There are three specific aims: 1) To test the hypothesis that the response of ?-cells to cytokine treatment is determined by a) the form of reactive oxygen species (ROS) or reactive nitrogen species (RNS) produced, and b) the ability of ROS and RNS to selectively regulate signaling cascades that control cellular repair/protective pathways or activate cell death cascades;2) To test the hypothesis that Ataxia telangiectasia mutated (ATM) plays a primary role in regulating the response(s) of ?-cells to cytokine- and nitric oxide-mediated damage;3) To test the hypothesis that the activation status of SIRT1 determines whether ?-cells respond to cytokine treatment with the induction of "protective pathways" or the stimulation of cell death cascades. A number of biochemical, molecular, immunological, cell biological and transgenic techniques will be utilized to investigate the cellular pathways through which nitric oxide and its reactive intermediates mediate ?-cell damage and the pathways that participate in the protection of ?-cells from cytokine-induced damage. It is hoped that insights into the mechanisms controlling the response of ?-cells to cytokines that are gained from these studies will influence the design of therapeutic strategies aimed at attenuating the loss of functional ?-cell mass during the development of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK052194-18A1
Application #
8654239
Study Section
Special Emphasis Panel (ZRG1-EMNR-T (02))
Program Officer
Appel, Michael C
Project Start
1998-01-01
Project End
2018-03-31
Budget Start
2014-04-02
Budget End
2015-03-31
Support Year
18
Fiscal Year
2014
Total Cost
$359,550
Indirect Cost
$124,550
Name
Medical College of Wisconsin
Department
Biochemistry
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Khan, Parvez; Idrees, Danish; Moxley, Michael A et al. (2014) Luminol-based chemiluminescent signals: clinical and non-clinical application and future uses. Appl Biochem Biotechnol 173:333-55
Salvatori, Alison S; Elrick, Mollisa M; Samson, Willis K et al. (2014) Neuronostatin inhibits glucose-stimulated insulin secretion via direct action on the pancreatic ?-cell. Am J Physiol Endocrinol Metab 306:E1257-63
Oleson, Bryndon J; Broniowska, Katarzyna A; Schreiber, Katherine H et al. (2014) Nitric oxide induces ataxia telangiectasia mutated (ATM) protein-dependent ?H2AX protein formation in pancreatic ? cells. J Biol Chem 289:11454-64
Freudenburg, Wieke; Gautam, Madhav; Chakraborty, Pradipta et al. (2013) Reduction in ATP levels triggers immunoproteasome activation by the 11S (PA28) regulator during early antiviral response mediated by IFNýý in mouse pancreatic ýý-cells. PLoS One 8:e52408
Broniowska, Katarzyna A; Diers, Anne R; Corbett, John A et al. (2013) Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation. Biochemistry 52:4364-72
Meares, Gordon P; Fontanilla, Dominique; Broniowska, Katarzyna A et al. (2013) Differential responses of pancreatic ýý-cells to ROS and RNS. Am J Physiol Endocrinol Metab 304:E614-22
Andreone, Teresa; Meares, Gordon P; Hughes, Katherine J et al. (2012) Cytokine-mediated *-cell damage in PARP-1-deficient islets. Am J Physiol Endocrinol Metab 303:E172-9
Baldwin, Aaron C; Green, Christopher D; Olson, L Karl et al. (2012) A role for aberrant protein palmitoylation in FFA-induced ER stress and ?-cell death. Am J Physiol Endocrinol Metab 302:E1390-8
Christmann, Benjamin S; Moran, Jason M; McGraw, Jennifer A et al. (2011) Ccr5 regulates inflammatory gene expression in response to encephalomyocarditis virus infection. Am J Pathol 179:2941-51
Hughes, Katherine J; Meares, Gordon P; Hansen, Polly A et al. (2011) FoxO1 and SIRT1 regulate beta-cell responses to nitric oxide. J Biol Chem 286:8338-48

Showing the most recent 10 out of 53 publications